Clinical Trial

Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-24
Trial Details
NCT Number NCT07532135
Lead Sponsor Chulalongkorn University
Conditions Healthy Volunteers, Non Diabetic Hyperglycemia
Enrollment 48 participants
Start Date 2025-10-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-24 (estimated)
Updated on ClinicalTrials.gov 2026-04-23